This page is part of the FHIR Specification (v3.2.0: R4 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3
Vocabulary Work Group | Maturity Level: N/A | Ballot Status: Informative |
FHIR Value set/code system definition for HL7 v2 table 0078 ( Interpretation Codes)
<ValueSet xmlns="http://hl7.org/fhir"> <id value="v2-0078"/> <meta> <profile value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/> </meta> <text> <status value="additional"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p> Interpretation Codes</p> <table class="grid"> <tr> <td> <b> Code</b> </td> <td> <b> Description</b> </td> <td> <b> Comment</b> </td> <td> <b> Version</b> </td> </tr> <tr> <td> < <a name=".60"> </a> </td> <td> Off scale low</td> <td> The result is below the minimum detection limit (the test procedure or equipment is the limiting factor).<p>Synonyms: Below analytical limit, low off scale</td> <td> from v2.1</td> </tr> <tr> <td> > <a name=".62"> </a> </td> <td> Off scale high</td> <td> The result is above the maximum quantifiable limit (the test procedure or equipment is the limiting factor).<p>Synonyms: Above analytical limit, high off scale</td> <td> added v2.2</td> </tr> <tr> <td> A <a name="A"> </a> </td> <td> Abnormal</td> <td> The result or observation value is outside the reference range or expected norm (as defined for the respective test procedure).<p>Note: Typically applies to non-numeric results.</td> <td> from v2.1</td> </tr> <tr> <td> AA <a name="AA"> </a> </td> <td> Critically abnormal</td> <td> The result or observation value is outside a reference range or expected norm at a level at which immediate action should be considered for patient safety (as defined for the respective test procedure).<p>[Note: Typically applies to non-numeric results. </td> <td> from v2.1</td> </tr> <tr> <td> AC <a name="AC"> </a> </td> <td> Anti-complementary substances present</td> <td> Deprecated</td> <td> added v2.7</td> </tr> <tr> <td> B <a name="B"> </a> </td> <td> Better</td> <td> The current result or observation value has improved compared to the previous result or observation value (the change is significant as defined in the respective test procedure).<p>N ote: This can be applied to quantitative or qualitative observations.</td> <td> added v2.2</td> </tr> <tr> <td> D <a name="D"> </a> </td> <td> Significant change down</td> <td> The current result has decreased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure).</td> <td> from v2.1</td> </tr> <tr> <td> DET <a name="DET"> </a> </td> <td> Detected</td> <td> The measurement of the specified component / analyte, organism or clinical sign above the limit of detection of the performed test or procedure.</td> <td> added v2.7</td> </tr> <tr> <td> H <a name="H"> </a> </td> <td> High</td> <td> The result for a quantitative observation is above the upper limit of the reference range (as defined for the respective test procedure).<p>Synonym: Above high normal</td> <td> from v2.1</td> </tr> <tr> <td> HH <a name="HH"> </a> </td> <td> Critically high</td> <td> The result for a quantitative observation is above a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure).<p& gt;Synonym: Above upper panic limits</td> <td> from v2.1</td> </tr> <tr> <td> HM <a name="HM"> </a> </td> <td> Hold for Medical Review</td> <td> Deprecated</td> <td> added v2.8</td> </tr> <tr> <td> HU <a name="HU"> </a> </td> <td> Very high</td> <td> Significantly high: A test result that is significantly higher than the reference (normal) or therapeutic interval, but has not reached the critically high value and might need special attention, as defined by the laboratory or the clinician.<p>Note:</td> <td> added v2.8.2</td> </tr> <tr> <td> I <a name="I"> </a> </td> <td> Intermediate</td> <td> Bacterial strain inhibited in vitro by a<p>concentration of an antimicrobial agent that is associated with<p>uncertain therapeutic effect.<p>Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Ter</td> <td> from v2.1</td> </tr> <tr> <td> IE <a name="IE"> </a> </td> <td> Insufficient evidence</td> <td> There is insufficient evidence that the species in question is a good target for therapy with the drug. A categorical interpretation is not possible.<p>Reference: EUCAST<p>Note : A MIC with "IE" and/or a comment may be reported (without an accompanying S,</td> <td> added v2.8.2</td> </tr> <tr> <td> IND <a name="IND"> </a> </td> <td> Indeterminate</td> <td> The specified component / analyte, organism or clinical sign could neither be declared positive / negative or detected / not detected by the performed test or procedure.</td> <td> added v2.7</td> </tr> <tr> <td> L <a name="L"> </a> </td> <td> Low</td> <td> The result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure).<p>Synonym: Below low normal</td> <td> added v2.2</td> </tr> <tr> <td> LL <a name="LL"> </a> </td> <td> Critically low</td> <td> The result for a quantitative observation is below a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure).<p& gt;Synonym: Below lower panic limits</td> <td> from v2.1</td> </tr> <tr> <td> LU <a name="LU"> </a> </td> <td> Very low</td> <td> Significantly low: A test result that is significantly lower than the reference (normal) or therapeutic interval, but has not reached the critically low value and might need special attention, as defined by the laboratory or the clinician.<p>Note: T</td> <td> added v2.8.2</td> </tr> <tr> <td> MS <a name="MS"> </a> </td> <td> Moderately susceptible. Indicates for microbiology susceptibilities only.</td> <td> Deprecated - CLSI now only supports S, I & R. This information can be found in CLSI document M100-S22; Vol. 32 No.3; CLSI Performance<p>Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012.</td> <td> from v2.1</td> </tr> <tr> <td> N <a name="N"> </a> </td> <td> Normal</td> <td> The result or observation value is within the reference range or expected norm (as defined for the respective test procedure).<p>Note: Applies to numeric or non-numeric results.</td> <td> added v2.2</td> </tr> <tr> <td> ND <a name="ND"> </a> </td> <td> Not Detected</td> <td> The presence of the specified component / analyte, organism or clinical sign could not be determined within the limit of detection of the performed test or procedure.</td> <td> added v2.7</td> </tr> <tr> <td> NEG <a name="NEG"> </a> </td> <td> Negative</td> <td> An absence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure.<p>Note: Negative does not necessarily imply the complete absence of the specified item.</td> <td> added v2.7</td> </tr> <tr> <td> NR <a name="NR"> </a> </td> <td> Non-reactive</td> <td> An absence finding used to indicate that the specified component / analyte did not react measurably with the reagent.</td> <td> added v2.7</td> </tr> <tr> <td> NS <a name="NS"> </a> </td> <td> Non-susceptible</td> <td> A category used for isolates for which only a susceptible interpretive criterion has been designated because of the absence or rare occurrence of resistant strains. Isolates that have MICs above or zone diameters below the value indicated for the suscepti</td> <td> added v2.8.2</td> </tr> <tr> <td> null <a name="null"> </a> </td> <td> No range defined, or normal ranges don't apply</td> <td> Deprecated</td> <td> from v2.1</td> </tr> <tr> <td> OBX <a name="OBX"> </a> </td> <td> Interpretation qualifiers in separate OBX segments</td> <td> Deprecated</td> <td> added v2.8</td> </tr> <tr> <td> POS <a name="POS"> </a> </td> <td> Positive</td> <td> A presence finding of the specified component / analyte, organism or clinical sign based on the established threshold of the performed test or procedure.</td> <td> added v2.7</td> </tr> <tr> <td> QCF <a name="QCF"> </a> </td> <td> Quality Control Failure</td> <td> Deprecated</td> <td> added v2.7</td> </tr> <tr> <td> R <a name="R"> </a> </td> <td> Resistant</td> <td> Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure.<p>Reference: CLSI (http://www.cls i.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmon</td> <td> from v2.1</td> </tr> <tr> <td> RR <a name="RR"> </a> </td> <td> Reactive</td> <td> A presence finding used to indicate that the specified component / analyte reacted with the reagent above the reliably measurable limit of the performed test.</td> <td> added v2.7</td> </tr> <tr> <td> S <a name="S"> </a> </td> <td> Susceptible</td> <td> Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success.<p>Reference: CLSI (http://www.clsi.o rg/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmoniz</td> <td> from v2.1</td> </tr> <tr> <td> SDD <a name="SDD"> </a> </td> <td> Susceptible-dose dependent</td> <td> A category that includes isolates with antimicrobial agent minimum inhibitory concentrations (MICs) that approach usually attainable blood and tissue levels and for which response rates may be lower than for susceptible isolates.<p>Reference: CLSI documen</td> <td> added v2.8.2</td> </tr> <tr> <td> SYN-R <a name="SYN-R"> </a> </td> <td> Synergy - resistant</td> <td> A category for isolates where the bacteria (e.g. enterococci) are not susceptible in vitro to a combination therapy (e.g. high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will not be effective.<p>Usa</td> <td> added v2.8.2</td> </tr> <tr> <td> SYN-S <a name="SYN-S"> </a> </td> <td> Synergy - susceptible</td> <td> A category for isolates where the bacteria (e.g. enterococci) are susceptible in vitro to a combination therapy (e.g. high-level aminoglycoside and cell wall active agent). This is predictive that this combination therapy will be effective.<p>Usage Note:</td> <td> added v2.8.2</td> </tr> <tr> <td> TOX <a name="TOX"> </a> </td> <td> Cytotoxic substance present</td> <td> Deprecated</td> <td> added v2.7</td> </tr> <tr> <td> U <a name="U"> </a> </td> <td> Significant change up</td> <td> The current result has increased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure).</td> <td> from v2.1</td> </tr> <tr> <td> VS <a name="VS"> </a> </td> <td> Very susceptible. Indicates for microbiology susceptibilities only.</td> <td> Deprecated - CLSI now only supports S, I & R. This information can be found in CLSI document M100-S22; Vol. 32 No.3; CLSI Performance<p>Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012.</td> <td> from v2.1</td> </tr> <tr> <td> W <a name="W"> </a> </td> <td> Worse</td> <td> The current result or observation value has degraded compared to the previous result or observation value (the change is significant as defined in the respective test procedure).<p>N ote: This can be applied to quantitative or qualitative observations.</td> <td> added v2.2</td> </tr> <tr> <td> WR <a name="WR"> </a> </td> <td> Weakly reactive</td> <td> A weighted presence finding used to indicate that the specified component / analyte reacted with the reagent, but below the reliably measurable limit of the performed test.</td> <td> added v2.7</td> </tr> </table> </div> </text> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status"> <valueString value="External"/> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"> <valueInteger value="0"/> </extension> <url value="http://hl7.org/fhir/ValueSet/v2-0078"/> <version value="2.8.2"/> <name value="v2 Interpretation Codes"/> <status value="active"/> <experimental value="false"/> <publisher value="HL7, Inc"/> <contact> <telecom> <system value="url"/> <value value="http://hl7.org"/> </telecom> </contact> <description value="FHIR Value set/code system definition for HL7 v2 table 0078 ( Interpretation Codes)"/> <immutable value="true"/> <compose> <include> <system value="http://hl7.org/fhir/v2/0078"/> </include> </compose> </ValueSet>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.